InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,849.56
(
0.09%
)
Post# of 15281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

funnyG986

Send PM Follow Ignore
Followers 532
Posts 31795
Boards Moderated 2
Alias Born 09/23/2010

funnyG986

Re: None

Wednesday, 10/11/2017 11:57:07 AM

Wednesday, October 11, 2017 11:57:07 AM

Post# of 15281
ATMS shows news on their website; they attended Rodman & Renshaw Investment Conference in September. Today's filing showing new institutional owner Michael Vasinkevich (Acumen) 13%
https://www.otcmarkets.com/financialReportViewer?symbol=ATMS&id=180565

If you google Michael Vasinkevich, you will find that he is the founding partner of Rodman & Renshaw Capital Group. News all pointing to Rodman & Renshaw Investment. Coincidence ?

Mr. Michael Vasinkevich serves as Senior Managing Director, Vice Chairman and Founding Partner of Rodman & Renshaw Capital Group, Inc., and served as its Senior Managing Director since July 2002.

Artemis Presentation Webcast – Rodman & Renshaw 19th Annual Global Investment Conference
Brian M. Culley, CEO of Artemis Therapeutics Inc. (OTCMKTS: ATMS), presents on the company at the Rodman & Renshaw 19th Annual Global Investor Conference.

Click here to view the webcast
Post navigation
http://www.artemis-therapeutics.com/2017/09/12/artemis-presentation-webcast-rodman-renshaw-19th-annual-global-investment-conference/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up